Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Category: Side Effect: Vision / Optical (blindness, macular edema, sudden vision loss)

Case Report: Retinal Vasculitis and Vitritis After Three Beovu Injections Followed by a Later Lucentis Treatment

December 17, 2020

Woman Had Severe Vision Loss with Retinal Occlusive Vasculitis, Worsening Intraocular Inflammation; Due to Beovu, Lucentis, or Both? (Posted by Tom Lamb at Drug Injury Watch) In the December 2020 edition of…
Continue reading…
Beovu Vision Loss Cases – A Medical Update: What is Known, Unknown, and Still Emerging as of December 2020

December 9, 2020

Potentially Life-Changing Beovu Side Effects, Root Cause Remains Uncertain, Medical Management Methods Being Developed (Posted by Tom Lamb at DrugInjuryWatch.com) From a December 1, 2020 Ocular Surgery News article, “Retina specialists receptive…
Continue reading…
Novartis Update on Patients Suffering from Retinal Vasculitis and/or Retinal Vascular Occlusion After Beovu Injections

November 17, 2020

November 2020 Report: Beovu Eye Side Effects Risks Higher for Beovu Patients with Prior Intraocular Inflammation and/or Vascular Occlusion (Posted by Tom Lamb at DrugInjuryWatch.com) We have known since early 2020 that…
Continue reading…
Beovu Lawsuits Filed Against Novartis for Patients Who Have Suffered Vision Loss Side Effects

October 30, 2020

Beovu Legal Cases Involve Retinal Artery Occlusion, Retinal Vasculitis, Intraocular Inflammation, Other Eye Problems (Posted by Tom Lamb at DrugInjuryWatch.com) Beovu (brolucizumab) is prescribed for the treatment of neovascular (wet) age-related macular…
Continue reading…
A Closer Look at the Vision-Related Side Effects Warnings Added with June 2020 Beovu Label Change

October 6, 2020

New Beovu Warnings for Endophthalmitis and Retinal Detachment as well as Retinal Vasculitis, Retinal Vascular Occlusion (Posted by Tom Lamb at DrugInjuryWatch.com) In June 2020 Novartis revised the Prescribing Information for Beovu…
Continue reading…
Beovu: Should Use of This Eye Drug be Suspended Until Safety Investigation is Finished?

September 29, 2020

Numerous Case Reports of Occlusive Retinal Vasculitis and Vision Loss in Patients Following Beovu Injections (Posted by Tom Lamb at DrugInjuryWatch.com) As early as May 2020 it was suggested by the authors…
Continue reading…
Safety of Beovu: A Lingering Issue Which Novartis Attempts to Counter with Recent Study Results

September 22, 2020

Recent Beovu Label Change in Europe Adds Information About Retinal Vasculitis and Retinal Vascular Occlusion (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-September 2020 Novartis announced the results of a Phase 3…
Continue reading…
Drug Safety Issue: Elmiron Side Effects Risks for Eye and Vision Appear to be Greater Than Bladder Treatment Benefits

September 10, 2020

Patients Consider Whether Relief from Bladder Pain is Worth Possibility of Elmiron-Associated Maculopathy and Other Eye Problems (Posted by Tom Lamb at DrugInjuryWatch.com) Approved by the FDA way back in 1996, Elmiron…
Continue reading…
Elmiron-Related Eye Problems Are Causing Patients to File Elmiron Lawsuits Against Pharmaceutical Companies

September 2, 2020

Medical Studies Find Elmiron "significantly increased odds of having atypical maculopathy" Such as Pigmentary Maculopathy (Posted by Tom Lamb at DrugInjuryWatch.com) Elmiron (pentosan polysulfate sodium / "PPS") was approved by the FDA…
Continue reading…
Possible Beovu Side Effects Discussed At American Society of Retina Specialists Annual Meeting In July 2020

July 28, 2020

Current Findings On Risks Of Occlusive Vasculitis And Vision Loss Following Beovu Injections For Treatment Of Wet AMD (Posted by Tom Lamb at DrugInjuryWatch.com) According to news reports, Beovu safety issues were…
Continue reading…